MedTech Competitors

Delisted . USA . 
Stock . MedTech Acquisition Corp
MTACDelisted Stock  USD 10.55  0.03  0.28%   
MedTech Acquisition Corp competes with Western Acquisition; as well as few others. The company conducts business under Capital Markets sector and is part of Financials industry. Analyzing MedTech Acquisition competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of MedTech Acquisition to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of MedTech Acquisition competition on your existing holdings.
  
Specify up to 10 symbols:
Hype
Prediction
LowEstimatedHigh
10.5510.5510.55
Details
Intrinsic
Valuation
LowRealHigh
8.918.9111.61
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as MedTech Acquisition. Your research has to be compared to or analyzed against MedTech Acquisition's peers to derive any actionable benefits. When done correctly, MedTech Acquisition's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in MedTech Acquisition Corp.

MedTech Acquisition Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between MedTech Acquisition and its competitors represents the degree of relationship between the price movements of corresponding delisted stocks. A correlation of about +1.0 implies that the price of MedTech and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of MedTech Acquisition Corp does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
NCAC
+ 0.92
XPAX
NCAC
+ 0.89
JAQCU
XPAX
+ 0.85
JAQCU
GMFIU
+ 0.66
NCAC
GMFIU
+ 0.59
XPAX
GMFIU
+ 0.54
JAQCU
  
High negative correlations   
FLFV
- 0.51
WAVS
FLFV
- 0.49
JAQCU
FLFV
- 0.44
NCAC
FLFV
- 0.44
XPAX
WAVS
- 0.29
SPCMU
GMFIU
- 0.25
FLFV

Risk-Adjusted Indicators

There is a big difference between MedTech Stock performing well and MedTech Acquisition Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze MedTech Acquisition's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
All Fundamental Data

MedTech Acquisition Competitive Analysis

The better you understand MedTech Acquisition competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, MedTech Acquisition's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across MedTech Acquisition's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
MTAC SPCMU JAQCU WAVS XPAX NCAC FLFV GMFIU
 0.28 
 10.55 
MedTech
 0.00 
 10.66 
Sound
 0.00 
 10.40 
Jupiter
 1.52 
 11.99 
Western
 0.1 
 10.39 
XPAC
 0.00 
 11.00 
Newcourt
 0.00 
 1.72 
FLFV
 0.00 
 11.10 
Aetherium
Market Volatility
(90 Days Market Risk)
Very steady
Very steady
Very steady
Not too volatile
Very steady
Very steady
Very steady
Very steady
Market Performance
(90 Days Performance)
Very Weak
Very Weak
Very Weak
Weak
Very Weak
Very Weak
Very Weak
Very Weak
Odds of Financial Distress
(Probability Of Bankruptcy)
Dangerous
Dangerous
Dangerous
Average
Dangerous
Dangerous
Dangerous
Dangerous
Current Valuation
(Equity Enterprise Value)
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Not Rated
Not Rated
Not Rated
Strong Sell
Not Rated
Not Rated
Not Rated
Not Rated
Current Ratio
0.15 X
0.10 X
2.19 X
0.01 X
0.21 X
3.05 X
N/A
0.08 X
Net Asset
20.19 M
271.47 M
160.16 M
3.41 M
223 M
258.93 M
54.14 M
32.93 M
EBITDA
(8.58 M)
N/A
(5.25 M)
(961.77 K)
(12.24 M)
(7.05 M)
(1.25 M)
(1.1 M)
Current Valuation
79.84 M
344.33 M
61.97 M
41.27 M
287.29 M
43.61 M
17.08 M
59.02 M
Price To Book
1.31 X
N/A
N/A
200.03 X
1.32 X
0.40 X
1.83 X
N/A
Retained Earnings
(13.27 M)
(10.85 M)
(5.9 M)
(3.2 M)
(14.94 M)
(13.9 M)
(6.12 M)
(7.25 M)
Beta
-0.0423
N/A
-0.085
-0.21
N/A
-0.058
N/A
0.039
Number Of Employees
3
4
3
N/A
3
3
4
2
Shares Outstanding
7.39 M
N/A
N/A
3.42 M
21.96 M
8.79 M
3.16 M
N/A
Cash Flow From Operations
(2.74 M)
N/A
(1.91 M)
(940.73 K)
(523.12 K)
(1.14 M)
(2.58 M)
(385.45 K)
Total Debt
2.37 M
10 K
132.6 K
204.22 K
300 K
90.09 K
2.16 M
1.42 M
Return On Equity
N/A
N/A
N/A
-0.29
N/A
N/A
N/A
N/A
Z Score
18.76
-0.05
-0.16
N/A
N/A
N/A
N/A
N/A
Return On Asset
-0.0193
-0.0039
-0.0175
-0.15
-0.0127
-0.0109
-0.0127
-0.0107
Number Of Shares Shorted
2.85 K
N/A
200
2.16 K
1.46 K
7.78 K
21.68 K
1.45 K
Book Value Per Share
(2.42) X
(0.34) X
(0.81) X
(0.90) X
(0.54) X
(1.83) X
(1.28) X
(1.32) X
Total Asset
20.19 M
271.47 M
160.16 M
3.41 M
223 M
258.93 M
54.14 M
32.93 M
Debt To Equity
1.77 %
N/A
8.70 %
5.87 %
6.14 %
N/A
N/A
4.98 %
Short Ratio
1.00 X
N/A
N/A
0.07 X
0.01 X
9.75 X
10.55 X
6.99 X
Shares Owned By Institutions
17.16 %
8.85 %
7.92 %
27.08 %
77.93 %
15.82 %
3.83 %
0.01 %
Market Capitalization
83.86 M
N/A
N/A
41.06 M
287 M
42.09 M
14.35 M
N/A
Price To Earning
31.28 X
N/A
76.25 X
N/A
N/A
N/A
N/A
N/A
Net Income
5.54 M
(20.86 K)
1.19 M
(1.03 M)
1.91 M
1.52 M
1.34 M
726.04 K
Earnings Per Share
0.05 X
N/A
0.13 X
(0.26) X
0.20 X
0.13 X
0.25 X
N/A
Shares Owned By Insiders
84.51 %
N/A
19.76 %
71.50 %
9.60 %
94.86 %
0.93 %
N/A
Working Capital
(2.14 M)
1.05 M
(248.76 K)
(3.19 M)
(5.08 M)
(13.07 M)
(2.77 M)
24.41 M
Cash And Equivalents
69.18 K
946.45 K
721.17 K
618.56 K
270.26 K
306.88 K
1.03 M
55.51 K
Cash Per Share
N/A
0.03 X
0.04 X
0.04 X
0.01 X
0.01 X
0.08 X
N/A
Day Typical Price
10.77
10.66
10.4
11.99
10.39
11.0
1.68
11.1
Accumulation Distribution
0.0589
N/A
N/A
N/A
0.0019
N/A
0.16
N/A
Market Facilitation Index
0.66
N/A
N/A
N/A
0.02
N/A
0.29
N/A
Daily Balance Of Power
(0.05)
0.0
0.0
9.2 T
0.5
0.0
N/A
0.0
Period Momentum Indicator
(0.03)
N/A
N/A
0.18
0.01
N/A
N/A
N/A
Rate Of Daily Change
1.0
1.0
1.0
1.02
1.0
1.0
1.0
1.0
Day Median Price
10.88
10.66
10.4
11.99
10.39
11.0
1.66
11.1
Price Action Indicator
(0.34)
N/A
N/A
0.09
0.005
N/A
0.065
N/A
Coefficient Of Variation
N/A
2806.2
574.17
1423.64
611.41
567.55
(497.26)
8973.39
Mean Deviation
N/A
0.2237
0.093
1.34
0.0619
0.1647
3.97
0.6269
Jensen Alpha
N/A
0.0177
0.0278
0.1433
0.0088
0.0483
(1.90)
0.0135
Total Risk Alpha
N/A
(0.0008)
0.0221
0.0925
0.0064
0.0391
(2.16)
(0.03)
Sortino Ratio
N/A
(0)
N/A
0.047
N/A
N/A
N/A
(0)
Downside Variance
N/A
2.86
N/A
7.02
N/A
N/A
N/A
15.14
Standard Deviation
N/A
0.7641
0.213
2.2
0.1171
0.3215
9.57
1.54
Kurtosis
N/A
29.07
14.65
2.28
9.67
12.24
39.98
6.55
Potential Upside
N/A
0.4735
0.3914
4.63
0.1946
0.6542
0.8264
3.07
Treynor Ratio
N/A
(0.75)
(0.72)
2.85
0.6057
(0.56)
1.18
(0.02)
Maximum Drawdown
N/A
8.48
1.38
12.07
0.6801
2.45
78.38
9.13
Variance
N/A
0.5838
0.0454
4.83
0.0137
0.1034
91.63
2.37
Market Risk Adjusted Performance
N/A
(0.74)
(0.71)
2.86
0.6157
(0.55)
1.19
(0.01)
Risk Adjusted Performance
N/A
0.0288
0.1163
0.0649
0.0753
0.1313
(0.16)
0.0139
Skewness
N/A
0.6048
3.19
0.3035
0.0437
2.54
(5.88)
(0.06)
Semi Deviation
N/A
0.5495
N/A
1.56
N/A
N/A
N/A
1.14
Information Ratio
N/A
(0)
0.0347
0.0567
(0.09)
0.0838
(0.20)
(0.01)
Value At Risk
N/A
(0.38)
N/A
(3.25)
(0.1)
(0.45)
(16.10)
(2.62)
Expected Short fall
N/A
(0.60)
N/A
(2.93)
N/A
N/A
N/A
(2.60)
Downside Deviation
N/A
1.69
N/A
2.65
N/A
N/A
N/A
3.89
Semi Variance
N/A
0.302
N/A
2.42
N/A
N/A
N/A
1.31

MedTech Acquisition Competition Performance Charts

Five steps to successful analysis of MedTech Acquisition Competition

MedTech Acquisition's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by MedTech Acquisition Corp in relation to its competition. MedTech Acquisition's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of MedTech Acquisition in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact MedTech Acquisition's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to MedTech Acquisition Corp, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your MedTech Acquisition position

In addition to having MedTech Acquisition in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Silver Thematic Idea Now

Silver
Silver Theme
Companies involved in mining, production, and distribution of silver and silver goods. The Silver theme has 40 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Silver Theme or any other thematic opportunities.
View All  Next Launch
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.

Other Consideration for investing in MedTech Stock

If you are still planning to invest in MedTech Acquisition Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the MedTech Acquisition's history and understand the potential risks before investing.
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Fundamental Analysis
View fundamental data based on most recent published financial statements
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY